Robert A. Milton Endowed Chair
Director, Center for ImmunoEngineering at Georgia Tech
Immunoengineering, stem cell engineering, biomaterials, drug and gene delivery, tissue engineering and regenerative medicine, cancer immunotherapy, HIV and HCV, autoimmune diseases, tissue regeneration, cell therapies
The overall goal of our research endeavor is the development of new biomaterial-based strategies for gene/drug delivery and stem cell engineering. Towards this, my laboratory focuses on three major directions: (a) design and development of novel delivery systems for nucleic-acid based immunotherapy and cancer chemotherapy (b) engineering complex microenvironments to study and manipulate stem cells and understand their behavior in biomimetic, three-dimensional conditions and (c) developing novel engineering tools and high throughput methods to generate functional T cells and Dendritic cells from stem cells.